, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

• Acta Medica Academica Vol. 51 No. 3 (2022) - Clinical Medicine
  Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group
  Abstract  PDF